IGC To Enter California Market With Hyalolex

IGC to Enter California Market with Hyalolex, its lead cannabis-based supplement for treating and managing Alzheimer’s patients.

MARYLAND: India Globalization Capital (IGC) has designated California as a priority market for Hyalolex, its lead cannabis-based supplement for treating and managing Alzheimer’s patients. “The cannabis market is showing explosive growth and we are aggressively moving forward with our vision of owning and marketing the leading brands for large medical indications such as Alzheimer’s, Parkinson’s, PTSD, Read the full article…

Puerto Rican Alzheimer’s Patients To Be First In U.S. To Obtain Cannabis-Based Relief

indoor grow

MARYLAND: Alzheimer’s patients in Puerto Rico will be the first in the United States to obtain Hyalolex, IGC’s proprietary cannabinoid based formulation aimed at relieving many of the symptoms of Alzheimer’s Disease, such as agitation, anxiety, sleep disorder, as well as caregiver distress, among others. Pursuant to an agreement between IGC and DaMa Pharmaceutical and its Read the full article…

Marijuana With A Side Of Ibuprofen: Buzz-Killing Rx For Alzheimer's?

The active ingredient in marijuana can calm inflammation in the brain, but its "high" is little help to those with neurodegenerative diseases.

As a drug, marijuana has certain effects and, depending on why you’re taking it, some side effects. And not everyone wants the whole package. New research finds that for patients who consider weed’s buzz an unwanted side effect, the answer might be as simple as taking an ibuprofen with their tetrahydrocannibinol (or THC). A study published Thursday in the Read the full article…

I Don't Want Alzheimer's Disease

People my age should start with mj products! I don't want Alzheimer's, so I definitely need weed in my life.

Well my goodness, I do learn something new every day. Did you know the cannabinoid HU 210 has been shown to prevent amyloid beta-promoted inflammation? The endocannabinoids anandamide and noladin ether have also been shown the be neuroprotective against amyloid beta in vitro. That means blocking amyloids in early Alzheimer’s has a profound effect on Read the full article…